— Field Study on Healthcare DX and AI Utilization in Indonesia and Vietnam —
CarbGeM Inc. (Headquarters: Shibuya-ku, Tokyo; CEO: Masakazu Nakajima; hereinafter “CarbGeM”) is pleased to announce that it has been selected “Global South Future-Oriented Co-Creation Program” by Japan’s Ministry of Economy, Trade and Industry (METI).
This grant program aims to support Japanese companies in expanding infrastructure and services into emerging and developing countries, commonly referred to as the “Global South.” It encourages forward-looking business development that addresses local social issues while strengthening sustainable development and economic cooperation between Japan and these regions.
The program particularly promotes the formation of co-creation business models leveraging Japan’s strengths in fields such as healthcare, education, and energy.
CarbGeM will conduct a feasibility study for implementing clinical testing and diagnostic support services utilizing a cloud-based AI image analysis digital platform in Indonesia and Vietnam.The study aims to enhance and streamline clinical testing and diagnostic support at healthcare institutions by evaluating the potential deployment of CarbGeM’s cloud-based AI platform tailored for medical settings.
Through this initiative, CarbGeM seeks to contribute to strengthening diagnostic infrastructure, improving human resource efficiency, and reducing healthcare disparities in regions with limited medical resources.
“CarbConnect®” is a cloud-based AI image analysis digital platform, provides real-time uploading, sharing, and analysis of images for healthcare and research institutions.
Key features include:
This platform enables stable and high-precision diagnostic services even in regions facing shortages of skilled professionals, helping to correct healthcare disparities and improve overall quality.
▶ For more details, please visit: https://carbgem.com/product/carbconnect/
Through cutting-edge AI technology, CarbGeM will continue to contribute to strengthening healthcare infrastructure and solving social issues across the Global South.
CarbGeM drives innovation in the life sciences sector by advancing diagnostic support, improving research efficiency, and promoting the standardization and automation of quality control.
The company actively addresses challenges such as skilled workforce shortages and regional disparities by delivering accurate and rapid results to support medical and industrial fields.
By leveraging AI technologies and digital platforms, CarbGeM strengthens collaboration among researchers and healthcare professionals, aiming to tackle global issues such as antimicrobial resistance (AMR).
The company is committed to co-creating the future through open innovation with leading domestic and international research institutions, fostering strong industry-academia-government partnerships.
